Umlaut.bio
Agent37Agent Readiness: 37/100. Below median. Measured by StartupHub.ai. Median 41.Trust76Data Trust: 76/100. Above median. Measured by StartupHub.ai. Median 61.Developing novel immunotherapies for cancer.
About
Umlaut.bio is a biotechnology company focused on developing novel immunotherapies for cancer. They leverage their proprietary platform to discover and develop new therapeutic candidates. The company has recently secured significant pre-seed funding to advance its research and development efforts.
Similar companies
Developing novel immunotherapies and diagnostics for cancer.
Shares Biotechnology, Cancer
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Shares Biotechnology, Immunotherapy
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
Shares Biotechnology, Drug Discovery
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Shares Biotechnology, Immunotherapy
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
Biotechnology company developing novel immunotherapies for cancer.
Shares Drug Discovery, Immunotherapy
Key facts
- Website
- umlaut.bio
- Headquarters
- Cambridge, Massachusetts, USA
- Founded
- 2022
- Total funding
- $3M (Pre-Seed)
- Business model
- B2B
Tech stack
Detected on umlaut.bio, last scanned 21 Oct 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery, Bootstrap
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Maps
- Google Maps
Umlaut.bio scores 7. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Umlaut.bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Umlaut.bio is 76 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Umlaut.bio raised?
Umlaut.bio has raised a total of $3M in funding. The most recent round on record is Pre-Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Umlaut.bio
